Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Gliosarcoma 10Glioblastoma 9Carcinoma, Non-Small-Cell Lung 5Salivary Gland Neoplasms 3Astrocytoma 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Pinealoma 2Pancreatic Neoplasms 2Medulloblastoma 2Head and Neck Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sarcoma 1Rectal Neoplasms 1Radiation Injuries 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lung Neoplasms 1

Interventions

Chemotherapy, Adjuvant 2Vincristine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Ototoxicity × Radiotherapy, Conformal × Clear all
NCT01216800 2010-10-07

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
84 enrolled
Head & Neck

Ototoxicity, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡